简体中文 | 繁體中文 | English

Surveys News

2022-05-05 14:36 1 in 2 girls are quitting sport due to periods, according to new global report by PUMA and Modibodi®
2022-04-26 15:38 Real-Time Payments Evolution Underway as Asia-Pacific Seeks New Growth Frontiers – ACI Worldwide Report
2022-04-26 15:00 2022 Africa Wealth Report Reveals ‘Big 5’ Hold over 50% of the Continent’s Private Wealth
2022-04-25 14:32 Experian Finds Mobile Wallets Rival Traditional Payment Methods
2022-04-18 10:11 Takeda’s TAKHZYRO® (lanadelumab) Open Label Phase 3 Study Met Its Objectives in Children Ages 2 to <12 Years of Age With Hereditary Angioedema (HAE)
2022-04-12 10:12 Rhizen Pharmaceuticals AG Presents Data on Its Differentiated PARP and DHODH Inhibitor Programs at AACR 2022
2022-04-01 09:00 One in Five Businesses Have Paid or Would Pay a Ransom for Their Data, Finds Thales
2022-03-30 10:00 Ingram Micro Cloud Publishes Cloud Technology: The State of MSPs Report Aimed at Guiding Reseller Success
2022-03-23 14:41 Bad Actors Innovate, Extort and Launch 9.7M DDoS Attacks in 2021 According to the Latest NETSCOUT Threat Intelligence Report
2022-03-23 10:35 American Express Travel: 2022 Global Travel Trends Report Shows People are Ready and Eager to Travel and Booking Trips with More Purpose Than Ever
2022-03-18 17:21 More Than Half of Physicians Have Been Asked By Patients for an Unapproved COVID-19 Treatment
2022-03-17 09:50 Jardiance® (empagliflozin) Phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease
2022-03-15 15:14 Nichi GLOW: Japanese Beta-Glucan, in Children With Autism Spectrum Disorder, Improves Behavior, Sleep, and Gut Microbiome in a Clinical Study
2022-03-01 09:32 Interim Phase 4 Data Support TAKHZYRO® (lanadelumab) as an Effective Treatment to Reduce Attacks in Hereditary Angioedema Patients
2022-02-22 13:35 CORRECTING and REPLACING 62% of Financial Services Leaders Expect Their Cloud Investments to Increase Revenue Over Next Two Years
2022-02-21 09:07 Long-Term Follow-Up Data Reinforce Continued Overall Survival Benefit of BAVENCIO® (avelumab) First-Line Maintenance Treatment in Patients with Advanced Urothelial Carcinoma
2022-02-18 11:33 New BitMEX Report Predicts Five Ways the World of Crypto Will Change in 2022
2022-02-14 15:38 Brewers Look to Drive Recovery as New Oxford Economics Study Confirms Beer’s Significant Global Economic Impact
2022-02-10 15:48 2022 Winter Olympics Win Gold in Streaming Viewership and Social Engagement
2022-02-10 14:06 Lenovo Climbs the List of Fortune’s 2022 World’s Most Admired Companies

Business Wire Weibo

Press Releases

Latest Releases